Explore more publications!

Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on October 20, 2025

Snellings Injury Law highlights education and early detection in support of Breast Cancer Awareness Month
Bilt Labs Declared the Best Direct-to-Consumer Custom Orthotics Provider Online, Revolutionizing Foot Health for All
Primer centro integral de insuficiencia cardíaca certificado fuera de los EE. UU.
NIDEK Inc. Distributes Medmont Meridia™ Vantage to U.S. Ophthalmologists and U.S. Optometrists
Clerri Paves the Way for More Accessible Dental Care with AI and Data Analytics
Comfort Keepers of Georgetown: Trusted Senior Care Providers in Georgetown, TX
NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards
XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Healios K.K. to Present at Chardan’s 9th Annual Genetic Medicines Conference
KFSHRC realiza la primera resección robótica de tumor intracraneal en el mundo... Una nueva era en la neurocirugía
KFSHRC Realiza a Primeira Ressecção Robótica de Tumor Intracraniano do Mundo... Uma Nova Era na Neurocirurgia
EMS HEALTH LLC Unveils New E-Commerce Platform NuGeneLabs.com for Holistic Wellness
BRAVE Trauma Therapist Collective Celebrates 3 Years as Leading Community for Trauma Therapists
Hapbee Announces R&D of Three New Frequency Wellness Signals for Hunger Management, Allergy Comfort, and Sexual Vitality; Closes Private Placement and Appoints Director
Bio Usawa Announces Approval of BioUcenta™ by the Rwandan FDA
Lirum Therapeutics Announces FDA “Study May Proceed” Letter Enabling Inclusion of LX-101 in the RAPID Platform Clinical Trial for Ewing Sarcoma and Desmoplastic Small Round Cell Tumor
BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase
BrightSpring Health Services, Inc. Reports Preliminary Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025
Verrica Pharmaceuticals Receives Positive Feedback from the European Medicines Agency (EMA) Supporting a Clear Regulatory Path Forward to File for Approval of YCANTH® in the European Union

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions